Dymicron Triadyme®-C: Revolutionary Polycrystalline Diamond Cervical
Total Disc Replacement

Orem, Utah 8/08/2024 – Dymicron is proud to announce the continued clinical success and sales expansion of its innovative cervical disc replacement device, Triadyme®-C, designed to significantly enhance the quality of life for patients suffering from cervical disc degeneration. As a state-of-the-art alternative to traditional fusion techniques, as well as earlier generations of cervical disc replacements, the Triadyme®-C disc not only preserves natural spinal mobility but also empowers patients to maintain an active lifestyle post-surgery.

Key Features of the Dymicron Triadyme®-C Cervical Disc Replacement:

• – Preserved Motion: Engineered to mimic the natural function of a healthy disc, promoting optimal spinal dynamics.
• – Advanced Materials: Created from biocompatible Polycrystalline Diamond to ensure exceptional durability while minimizing the risk of complications due to wear debris generation.
• – Minimally Invasive Technique: Generally implanted using minimally invasive methods, potentially leading to quicker recovery times and reduced hospital stays.
• – Proven Clinical Results: Backed by over 800 implantations world-wide, exceptional clinical results, and excellent patient satisfaction and outcomes.

Dymicron continues to exceed its sales milestones with continued strong performance in Germany bolstered by a newly hired, seasoned salesperson accelerating our clinical adoption in the region. Our distribution network has expanded through partnerships with world-class distributers in Spain, Panama, and Mexico, and ongoing collaborations in South America. We are pleased to announce the successful completion of our QMS audit with our notified body and the extension of our MDD certification (CE Mark), ensuring uninterrupted sales across Europe and other global markets. Additionally, we are making significant progress towards finalization of our Investigational Device Exemption (IDE) application with FDA within the next few months. Once submitted, we anticipate approval to commence clinical trials in the United States shortly thereafter. With a commitment to innovation and excellence, Dymicron is positioned to quickly become a leading provider of cervical total disc replacement solutions by taking significant market share due to the Triadyme®-C’s combination of revolutionary, wear-limiting, polycrystalline diamond material and exceptional tri-lobe design biomechanics.

For additional information, please contact:
IR@Dymicron.com

Or visit our website at:
www.Dymicron.com